Quotient (QTNTQ)
OTHER OTC:QTNTQ

Quotient (QTNTQ) Stock Price & Analysis

199 Followers

QTNTQ Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.03 - $23.60
Previous Close$0.03
Volume11.45K
Average Volume (3M)13.88K
Market Cap
$137.59K
Enterprise Value$260.60M
Total Cash (Recent Filing)$11.93M
Total Debt (Recent Filing)$272.39M
Price to Earnings (P/E)0.0
Beta0.10
Aug 07, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-38.91
Shares Outstanding21,055,013
10 Day Avg. Volume6,735
30 Day Avg. Volume13,884
Standard Deviation0.31
R-Squared0.17
Alpha-0.11
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.03
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.97
Enterprise Value/Gross Profit17.44
Enterprise Value/Ebitda-3.15
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

QTNTQ FAQ

What was Quotient’s price range in the past 12 months?
Quotient lowest stock price was $0.03 and its highest was $23.60 in the past 12 months.
    What is Quotient’s market cap?
    Currently, no data Available
    When is Quotient’s upcoming earnings report date?
    Quotient’s upcoming earnings report date is Aug 07, 2023 which is in 66 days.
      How were Quotient’s earnings last quarter?
      Currently, no data Available
      Is Quotient overvalued?
      According to Wall Street analysts Quotient’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Quotient pay dividends?
        Quotient does not currently pay dividends.
        What is Quotient’s EPS estimate?
        Quotient’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Quotient have?
        Quotient has 4,035,013 shares outstanding.
          What happened to Quotient’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Quotient?
          Among the largest hedge funds holding Quotient’s share is Highbridge Capital Management LLC. It holds Quotient’s shares valued at N/A.

            ---

            Quotient Stock Smart Score

            N/A
            Not Ranked
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10
            This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
            Learn more about TipRanks Smart Score

            Company Description

            Quotient

            Quotient Ltd. is a commercial-stage diagnostics company. It provides immunohematology products to hospitals and blood banks. The company develops, manufactures and sells conventional reagent products to equipment manufacturers. It engages in transfusion diagnostics, which focuses on blood grouping and serological disease screening. Quotient was founded on January 28, 2012 and is headquartered in Eysins, Switzerland.

            ---

            Forecast EPS vs Actual EPS

            Currently, no data available
            Please return soon. This page is being updated.

            Similar Stocks
            Company
            Price & Change
            Follow
            Lineage Therap
            Centogene NV
            Bellicum Pharmaceuticals
            Rockwell Med

            Popular Stocks

            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis